Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C GONICK

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Toxicology and Environmental Health|March 1, 1981
Erythrocyte lead-binding protein after occupational exposure. II. Influence on lead inhibition of membrane Na+,K+-adenosinetriphosphataseS R Raghavan, B D Culver, H C Gonick
Current Problems in Clinical Biochemistry|January 1, 1979
Comparison of serum and urine fibrin split products and urinary beta-glucuronidase in the diagnosis of renal transplant rejectionH C Gonick, E R Stiehm, L F Saldanha
The American Journal of Medicine|July 1, 1975
Silicon nephropathyL F Saldanha, V J Rosen, H C Gonick
Kidney International|November 5, 1997
Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapyN D Vaziri, Y Ding, Z Ni, et al.
Clinical Science and Molecular Medicine|October 1, 1977
Circulating inhibitor of sodium-potassium-activated adenosine triphosphatase after expansion of extracellular fluid volume in ratsH C Gonick, H J Kramer, W Paul, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Mineral balance (iron, aluminum, copper, zinc) after high-dose intravenous Desferal in a child with hemoglobin Hammersmith and Turner's syndromeC B Hyman, H C Gonick, N Neufeld, et al.
Biological Trace Element Research|November 23, 2013
Clinical trial of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic menM B Rabinowitz, H C Gonick, S R Levin, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factorsH C Gonick, E W Weiler, B A Prins, et al.
American Journal of Hypertension|August 1, 1993
Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertensionH C Gonick, E W Weiler, F Khalil-Manesh, et al.
American Journal of Hypertension|March 13, 2001
Lead-induced hypertension. III. Increased hydroxyl radical productionY Ding, H C Gonick, N D Vaziri, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Toxicology and Environmental Health|March 1, 1981
Erythrocyte lead-binding protein after occupational exposure. II. Influence on lead inhibition of membrane Na+,K+-adenosinetriphosphataseS R Raghavan, B D Culver, H C Gonick
Current Problems in Clinical Biochemistry|January 1, 1979
Comparison of serum and urine fibrin split products and urinary beta-glucuronidase in the diagnosis of renal transplant rejectionH C Gonick, E R Stiehm, L F Saldanha
The American Journal of Medicine|July 1, 1975
Silicon nephropathyL F Saldanha, V J Rosen, H C Gonick
Kidney International|November 5, 1997
Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapyN D Vaziri, Y Ding, Z Ni, et al.
Clinical Science and Molecular Medicine|October 1, 1977
Circulating inhibitor of sodium-potassium-activated adenosine triphosphatase after expansion of extracellular fluid volume in ratsH C Gonick, H J Kramer, W Paul, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Mineral balance (iron, aluminum, copper, zinc) after high-dose intravenous Desferal in a child with hemoglobin Hammersmith and Turner's syndromeC B Hyman, H C Gonick, N Neufeld, et al.
Biological Trace Element Research|November 23, 2013
Clinical trial of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic menM B Rabinowitz, H C Gonick, S R Levin, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factorsH C Gonick, E W Weiler, B A Prins, et al.
American Journal of Hypertension|August 1, 1993
Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertensionH C Gonick, E W Weiler, F Khalil-Manesh, et al.
American Journal of Hypertension|March 13, 2001
Lead-induced hypertension. III. Increased hydroxyl radical productionY Ding, H C Gonick, N D Vaziri, et al.
Pageof 6